Krsnaa Diagnostics is Live on SOPHiA GENETICS

Apr 11 2023
SOPHiA DDM™ for Hereditary Cancers Enables Krsnaa Diagnostics to Expand its NGS Offerings BOSTON & LAUSANNE, Switzerland --(BUSINESS WIRE)--Apr. 11, 2023-- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced

Read more

Build something bigger than your career

Enjoyed learning about life at SOPHiA from our blogs? Here are a few of our open roles

Title Country Department
IVDR Expert (Regulatory Affairs) Switzerland. United Kingdom. United States Regulatory & Quality
Subject Matter Expert - APAC Malaysia. Singapore Clinical Sales
Senior Director, Clinical & BioPharma Operations Switzerland Medical
Sr Manager, Genomic Implementation Solutions United States Clinical Sales
Deal Desk and Commercial Operations Manager Switzerland. United States Clinical Sales